|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal Susitarimą)
| (51) | INT.CL. | C07K 5/00 | |
| C07K 1/00 | |||
| C07K 14/00 |
| (11) | Patento numeris | 2316845 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 10075639.4 |
| Europos patento paraiškos padavimo data | 2002-10-11 | |
| (97) | Europos patento paraiškos paskelbimo data | 2011-05-04 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2013-01-16 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (30) | Numeris | Data | Šalis |
| 328624 P | 2001-10-11 | US | |
| 414155 P | 2002-09-27 | US | |
| 269695 | 2002-10-10 | US |
| (72) |
Oliner, Jonathan Daniel, US
Min, Hosung, US
|
| (73) |
Amgen Inc.,
One Amgen Center Drive, Thousand Oaks, CA 91320-1799,
US
|
| (54) | Specific binding agents of human angiopoietin-2 |
| Specific binding agents of human angiopoietin-2 |